Stock CPRX CATALYST PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Catalyst Pharmaceuticals, Inc.

Equities

CPRX

US14888U1016

Real-time Estimate Cboe BZX
Other stock markets
 09:57:58 2024-05-17 am EDT 		5-day change 1st Jan Change
16.48 USD +0.46% Intraday chart for Catalyst Pharmaceuticals, Inc. +3.14% -2.20%
May. 15 Transcript : Catalyst Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM
May. 10 HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CATALYST PHARMACEUTICALS, INC. Stock Catalyst Pharmaceuticals, Inc.
 1.94B -
CSL LIMITED Stock CSL Limited
 92.59B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 41.43B
BIOGEN INC. Stock Biogen Inc.
 33.49B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 14.62B
INCYTE CORPORATION Stock Incyte Corporation
 12.77B
  1. Stock Market
  2. Equities
  3. CPRX Stock
  4. Charts Catalyst Pharmaceuticals, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW